Below are all available peer-reviewed research publications authored by Dr. Amol S. Navathe, MD, PhD, The Parity Center, and/or our associated collaborators.
Early Findings From Medicare’s End-Stage Renal Disease Treatment Choices Model
This work examines Medicare's End-Stage Renal Disease Treatment Choices (ETC) Model and reviews the efficacy of this model as policy implementation.
Tummalapalli SL, Navathe AS, Ibrahim SA. Early Findings From Medicare’s End-Stage Renal Disease Treatment Choices Model. JAMA Health Forum. 2022;3(10):e223500. doi:10.1001/jamahealthforum.2022.3500
The study results suggest that low-value care is less common in Medicare Advantage than Traditional Medicare, with elements of insurance design present in Medicare Advantage associated with fewer low-value services.
Boudreau E, Schwartz R, Schwartz AL, et al. Comparison of Low-Value Services Among Medicare Advantage and Traditional Medicare Beneficiaries. JAMA Health Forum. 2022;3(9):e222935. doi:10.1001/jamahealthforum.2022.2935
Selection and Causal Effects in Voluntary Programs: Bundled Payments in Medicare
